Cell metabolismPub Date : 2025-04-02DOI: 10.1016/j.cmet.2025.03.006
Mingge Ding, Rui Shi, Yanyan Du, Pan Chang, Tian Gao, Dema De, Yunan Chen, Man Li, Jun Li, Ke Li, Shuli Cheng, Xiaoming Gu, Juan Li, Shumiao Zhang, Na Feng, Jianzheng Liu, Min Jia, Rong Fan, Jianming Pei, Chao Gao, Feng Fu
{"title":"O-GlcNAcylation-mediated endothelial metabolic memory contributes to cardiac damage via small extracellular vesicles","authors":"Mingge Ding, Rui Shi, Yanyan Du, Pan Chang, Tian Gao, Dema De, Yunan Chen, Man Li, Jun Li, Ke Li, Shuli Cheng, Xiaoming Gu, Juan Li, Shumiao Zhang, Na Feng, Jianzheng Liu, Min Jia, Rong Fan, Jianming Pei, Chao Gao, Feng Fu","doi":"10.1016/j.cmet.2025.03.006","DOIUrl":"https://doi.org/10.1016/j.cmet.2025.03.006","url":null,"abstract":"Diabetic individuals with well-controlled blood glucose still have an increased risk of heart failure. This process may be mediated by metabolic memory, a phenomenon showing that hyperglycemia has long-term negative effects even after normoglycemia. Here, we found that despite later normoglycemia with insulin, long-term diabetes-derived plasma small extracellular vesicle (sEV) miR-15-16 exhibited sustained deleterious effects on cardiomyocytes and induced cardiac dysfunction in healthy animals, displaying a memory feature. Artery endothelial cells were the primary origin of sEV miR-15-16. Mechanistically, the continuous sEV miR-15-16 release is due to the sustained activation of CaMK2a following the high glucose-elicited positive feedback loop of CaMK2a/O-GlcNAcylation in endothelial cells. In patients with diabetes, elevated sEV miR-15-16 was significantly associated with cardiac dysfunction, regardless of blood glucose or HbA1c. Together, our findings demonstrate that diabetes-induced O-GlcNAcylation and activation of CaMK2a mediate endothelial metabolic memory, which induces continuous release of sEV miR-15-16 and subsequent cardiac damage.","PeriodicalId":9840,"journal":{"name":"Cell metabolism","volume":"10 1","pages":""},"PeriodicalIF":29.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143758395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cell Metabolism 20th anniversary Voices: Part 1 of 3","authors":"Zoltan Arany, Bao-Liang Song, Roberto Coppari, Jiandie Lin, Nada Kalaany, Gregory Steinberg","doi":"10.1016/j.cmet.2025.03.005","DOIUrl":"https://doi.org/10.1016/j.cmet.2025.03.005","url":null,"abstract":"In January 2005, <em>Cell Metabolism</em> released its very first issue, and this year we are proud to celebrate 20 years of publishing broadly impactful metabolic research. In this Voices series, we highlight individuals who, like <em>Cell Metabolism</em>, were just starting out in the metabolism field when they published in the pages of the first issues of this new journal. Over the past 20 years, these authors have continued their journeys in metabolism research, developing their own careers and their own laboratories, and they continue to be authors with us today. It is an honor to hear from these investigators and feel that the journal was a part of their own scientific journeys, and their careers part of ours.","PeriodicalId":9840,"journal":{"name":"Cell metabolism","volume":"20 1","pages":""},"PeriodicalIF":29.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143745600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell metabolismPub Date : 2025-04-01DOI: 10.1016/j.cmet.2025.03.007
Henrique Camara, Brian I. Park, Yu-Hua Tseng
{"title":"Feeling the pressure: PIEZO2-positive sensory neurons regulate adipose function","authors":"Henrique Camara, Brian I. Park, Yu-Hua Tseng","doi":"10.1016/j.cmet.2025.03.007","DOIUrl":"https://doi.org/10.1016/j.cmet.2025.03.007","url":null,"abstract":"Adipose tissue adapts to metabolic challenges through multiple regulatory mechanisms, including neuronal input. Although sympathetic neuronal regulation is well established, the impact of sensory feedback remains elusive. In this issue of <em>Cell Metabolism</em>, two studies reveal that sensory neurons expressing PIEZO2 modulate adipose function by inhibiting sympathetic output, reshaping our understanding of adipose surveillance and metabolism.","PeriodicalId":9840,"journal":{"name":"Cell metabolism","volume":"58 1","pages":""},"PeriodicalIF":29.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143745420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell metabolismPub Date : 2025-04-01DOI: 10.1016/j.cmet.2025.03.008
Scott L. Friedman
{"title":"Can we talk? The cryptic communications of hepatic stellate cells in lipid metabolism","authors":"Scott L. Friedman","doi":"10.1016/j.cmet.2025.03.008","DOIUrl":"https://doi.org/10.1016/j.cmet.2025.03.008","url":null,"abstract":"The contributions of signals generated by hepatic stellate cells that regulate hepatocyte lipid and glucose homeostasis are largely unexplored. The article by Hansen et al. introduces a novel role of plasmalemma vesicle-associated protein (PLVAP), a membrane protein expressed by hepatic stellate cells, in regulating these pathways in hepatocytes during fasting.","PeriodicalId":9840,"journal":{"name":"Cell metabolism","volume":"25 1","pages":""},"PeriodicalIF":29.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143745602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell metabolismPub Date : 2025-04-01DOI: 10.1016/j.cmet.2025.02.003
Shuqin Zeng, Alexandre Almeida, Dezhi Mu, Shaopu Wang
{"title":"Embracing the unknown: Proteomic insights into the human microbiome","authors":"Shuqin Zeng, Alexandre Almeida, Dezhi Mu, Shaopu Wang","doi":"10.1016/j.cmet.2025.02.003","DOIUrl":"https://doi.org/10.1016/j.cmet.2025.02.003","url":null,"abstract":"Protein-level investigations into the human microbiome provide insights into active microbial functions. Recently, Valdés-Mas et al.<span><span><sup>1</sup></span></span> introduced a metagenome-informed metaproteomics approach to functionally explore species-level microbiome-host interactions and quantify the dietary exposome. Its potential has been implemented in mice and humans to uncover proteomic signatures of health and inflammatory bowel disease.","PeriodicalId":9840,"journal":{"name":"Cell metabolism","volume":"5 1","pages":""},"PeriodicalIF":29.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143745351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell metabolismPub Date : 2025-03-31DOI: 10.1016/j.cmet.2025.03.002
Jamal Naderi, Amanda Kelsey Johnson, Himani Thakkar, Bhawna Chandravanshi, Alec Ksiazek, Ajay Anand, Vinnyfred Vincent, Aaron Tran, Anish Kalimireddy, Pratibha Singh, Ayushi Sood, Aasthika Das, Chad Lamar Talbot, Isabella A. Distefano, J. Alan Maschek, James Cox, Ying Li, Scott A. Summers, Donald J. Atkinson, Tursun Turapov, Bhagirath Chaurasia
{"title":"Ceramide-induced FGF13 impairs systemic metabolic health","authors":"Jamal Naderi, Amanda Kelsey Johnson, Himani Thakkar, Bhawna Chandravanshi, Alec Ksiazek, Ajay Anand, Vinnyfred Vincent, Aaron Tran, Anish Kalimireddy, Pratibha Singh, Ayushi Sood, Aasthika Das, Chad Lamar Talbot, Isabella A. Distefano, J. Alan Maschek, James Cox, Ying Li, Scott A. Summers, Donald J. Atkinson, Tursun Turapov, Bhagirath Chaurasia","doi":"10.1016/j.cmet.2025.03.002","DOIUrl":"https://doi.org/10.1016/j.cmet.2025.03.002","url":null,"abstract":"Ceramide accumulation impairs adipocytes’ ability to efficiently store and utilize nutrients, leading to energy and glucose homeostasis deterioration. Using a comparative transcriptomic screen, we identified the non-canonical, non-secreted fibroblast growth factor FGF13 as a ceramide-regulated factor that impairs adipocyte function. Obesity robustly induces FGF13 expression in adipose tissue in mice and humans and is positively associated with glycemic indices of type 2 diabetes. Pharmacological or genetic inhibition of ceramide biosynthesis reduces FGF13 expression. Using mice with loss and gain of function of FGF13, we demonstrate that FGF13 is both necessary and sufficient to impair energy and glucose homeostasis independent of ceramides. Mechanistically, FGF13 exerts these effects by inhibiting mitochondrial content and function, metabolic elasticity, and caveolae formation, which cumulatively impairs glucose utilization and thermogenesis. These studies suggest the therapeutic potential of targeting FGF13 to prevent and treat metabolic diseases.","PeriodicalId":9840,"journal":{"name":"Cell metabolism","volume":"53 1","pages":""},"PeriodicalIF":29.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143736964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell metabolismPub Date : 2025-03-31DOI: 10.1016/j.cmet.2025.03.004
Eva M. Pålsson-McDermott, Luke A.J. O’Neill
{"title":"Gang of 3: How the Krebs cycle-linked metabolites itaconate, succinate, and fumarate regulate macrophages and inflammation","authors":"Eva M. Pålsson-McDermott, Luke A.J. O’Neill","doi":"10.1016/j.cmet.2025.03.004","DOIUrl":"https://doi.org/10.1016/j.cmet.2025.03.004","url":null,"abstract":"The reprogramming of metabolic pathways and processes in immune cells has emerged as an important aspect of the immune response. Metabolic intermediates accumulate as a result of metabolic adaptations and mediate functions outside of metabolism in the regulation of immunity and inflammation. In macrophages, there has been a major focus on 3 metabolites linked to the Krebs cycle, itaconate, succinate, and fumarate, which have been shown to regulate multiple processes. Here, we discuss recent progress on these 3 metabolites with regard to their effect on macrophages in host defense and inflammatory diseases. We also consider the therapeutic opportunities presented from the mimicry of these metabolites or by targeting the enzymes that make or metabolize them in order to leverage the body’s own anti-inflammatory response.","PeriodicalId":9840,"journal":{"name":"Cell metabolism","volume":"36 1","pages":""},"PeriodicalIF":29.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143736965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell metabolismPub Date : 2025-03-28DOI: 10.1016/j.cmet.2025.03.001
Kan Xie, Chengfeng Wang, Enzo Scifo, Brandon Pearson, Devon Ryan, Kristin Henzel, Astrid Markert, Kristina Schaaf, Xue Mi, Xin Tian, Jiajia Jia, Meiqin Wang, Stefan Bonn, Manuel Schölling, Christoph Möhl, Daniele Bano, Yu Zhou, Dan Ehninger
{"title":"Intermittent fasting boosts sexual behavior by limiting the central availability of tryptophan and serotonin","authors":"Kan Xie, Chengfeng Wang, Enzo Scifo, Brandon Pearson, Devon Ryan, Kristin Henzel, Astrid Markert, Kristina Schaaf, Xue Mi, Xin Tian, Jiajia Jia, Meiqin Wang, Stefan Bonn, Manuel Schölling, Christoph Möhl, Daniele Bano, Yu Zhou, Dan Ehninger","doi":"10.1016/j.cmet.2025.03.001","DOIUrl":"https://doi.org/10.1016/j.cmet.2025.03.001","url":null,"abstract":"Aging affects reproductive capabilities in males through physiological and behavioral alterations, including endocrine changes and decreased libido. In this study, we investigated the influence of intermittent fasting (IF) on these aging-related declines, using male C57BL/6J mice. Our findings revealed that IF significantly preserved reproductive success in aged mice, not by improving traditional reproductive metrics such as sperm quality or endocrine functions but by enhancing mating behavior. This behavioral improvement was attributed to IF’s ability to counter age-dependent increases in serotonergic inhibition, primarily through the decreased supply of the serotonin precursor tryptophan from the periphery to the brain. Our research underscores the potential of dietary interventions like IF in mitigating age-associated declines in male reproductive health and suggests a novel approach to managing conditions related to reduced sexual desire, highlighting the complex interplay between diet, metabolism, and reproductive behavior.","PeriodicalId":9840,"journal":{"name":"Cell metabolism","volume":"59 1","pages":""},"PeriodicalIF":29.0,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143723811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell metabolismPub Date : 2025-03-20DOI: 10.1016/j.cmet.2025.02.009
Yichao Zhao, Ling Gao, Jianqing Chen, Jingze Wei, Guanqiao Lin, Kewei Hu, Wubin Zhao, Weijun Wei, Wei Huang, Lingchen Gao, Ancai Yuan, Kun Qian, Alex F. Chen, Jun Pu
{"title":"Remote limb ischemic conditioning alleviates steatohepatitis via extracellular vesicle-mediated muscle-liver crosstalk","authors":"Yichao Zhao, Ling Gao, Jianqing Chen, Jingze Wei, Guanqiao Lin, Kewei Hu, Wubin Zhao, Weijun Wei, Wei Huang, Lingchen Gao, Ancai Yuan, Kun Qian, Alex F. Chen, Jun Pu","doi":"10.1016/j.cmet.2025.02.009","DOIUrl":"https://doi.org/10.1016/j.cmet.2025.02.009","url":null,"abstract":"Metabolic dysfunction-associated steatohepatitis (MASH) is an advanced form of liver disease with adverse outcomes. Manipulating interorgan communication is considered a promising strategy for managing metabolic disease, including steatohepatitis. Here, we report that remote limb ischemic conditioning (RIC), a clinically validated therapy for distant organ protection by transient muscle ischemia, significantly alleviated steatohepatitis in different mouse models. The beneficial effect of limb ischemic conditioning was mediated by muscle-to-liver transfer of small extracellular vesicles (sEVs) and their cargo microRNAs, leading to elevation of miR-181d-5p in the liver. Hepatic miR-181d-5p overexpression faithfully mirrored the molecular and histological benefits of limb ischemic conditioning by suppressing nuclear receptor 4A3 (NR4A3). Furthermore, circulating EVs from human volunteers undergoing limb ischemic conditioning improved steatohepatitis and transcriptomic perturbations in primary human hepatocytes and animal models. Our data underscore the translational potential of limb ischemic conditioning for steatohepatitis management and extend our understanding of muscle-liver crosstalk.","PeriodicalId":9840,"journal":{"name":"Cell metabolism","volume":"56 1","pages":""},"PeriodicalIF":29.0,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143660408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}